CORRESP Filing
EKSO BIONICS HOLDINGS, INC.
Date: April 15, 2025 · CIK: 0001549084 · Accession: 0001437749-25-012084
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286463
Letter
ekso20250415_corresp.htm
April 15, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention:
Mitchell Austin
Re:
Ekso Bionics Holdings, Inc.
Registration Statement on Form S-3
File No. 333-286463
Filed on April 10, 2025
Acceleration Request
Requested Date: April 17, 2025
Requested Time: 4:30 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ekso Bionics Holdings, Inc. hereby requests that its Registration Statement on Form S-3 (File No. 333-286463) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410.
Sincerely,
EKSO BIONICS HOLDINGS, INC.
Show Raw Text
CORRESP 1 filename1.htm ekso20250415_corresp.htm April 15, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Mitchell Austin Re: Ekso Bionics Holdings, Inc. Registration Statement on Form S-3 File No. 333-286463 Filed on April 10, 2025 Acceleration Request Requested Date: April 17, 2025 Requested Time: 4:30 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ekso Bionics Holdings, Inc. hereby requests that its Registration Statement on Form S-3 (File No. 333-286463) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410. Sincerely, EKSO BIONICS HOLDINGS, INC. By: /s/ Scott G. Davis Scott G. Davis Chief Executive Officer cc: Mark B. Baudler, Wilson Sonsini Goodrich & Rosati Austin D. March, Wilson Sonsini Goodrich & Rosati